Riskpilot← Back to searchSign inGet full accessGynenergi AB
ABActiveOrg 5569361552Fleminggatan 34 Lgh 1403Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2025
SEK 0
EBITDA margin
—
-440% vs 2024
Equity ratio
79.5%
Financial strength
Net profit 2025
SEK 300K
+18% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -269K | -440% |
| Net profit | SEK 300K | +18% |
| Total assets | SEK 441K | -3% |
| Equity | SEK 350K | -5% |
| Employees | 1 | — |
Legal name
Gynenergi AB
Org number
5569361552
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 juli 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsult arbete som specialistläkare, kostrådgivning och utbildning inom medicin, och handel med värdepapper samt därmed förenlig verksamhet.
Address
Fleminggatan 34 Lgh 1403
Phone
+46736388334
Email
katarina.mondzo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 375 | 335 | 465 | 276 | 0 |
| Staff expenses | — | −101 | −108 | −68 | −119 |
| EBITDA | 238 | 94 | 215 | 79 | −269 |
| Depreciation & amort. | −4 | — | — | — | — |
| EBIT | 234 | 94 | 215 | 79 | −269 |
| Net financials | −1 | −0 | −0 | 222 | 647 |
| Profit before tax | 234 | 74 | 215 | 321 | 378 |
| Tax | −48 | −15 | −44 | −66 | −78 |
| Net profit | 186 | 59 | 171 | 255 | 300 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 334 | 200 | 357 | 456 | 441 |
| Equity | 236 | 145 | 266 | 370 | 350 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 98 | 35 | 71 | 85 | 90 |
| Total debt | 98 | 35 | 71 | 85 | 90 |
EBITDA margin
-26852900.0%
This company
15.8%
Market median
-169955163% vs market
20212025
Equity ratio
79.5%
This company
38.2%
Market median
+108% vs market
20212025
Return on equity
85.6%
This company
18.4%
Market median
+365% vs market
20212025
Net profit margin
29997900.0%
This company
8.1%
Market median
+370344344% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gynenergi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katarina Elisabet Lampén Mondzo | Chief Executive Officer | 0 companies |
| Guy-Raymond Mondzo | Deputy Board Member | 0 companies |